Similar metabolic results were observed with genetic Sirt3 depletion in Karpas 422 cells, suggesting that the effects of YC8-02 in DLBCL models are mediated by Sirt3 inhibition [194]. This evidence concerns the gene SIRT3 and diffuse large B-cell lymphoma.